Esobiotec

Developer of in vivo adoptive cell therapies for cancer and autoimmune diseases. This involves engineering immune cells directly within the patient's body, eliminating the need for complex ex vivo manufacturing and reduc

placeMont-Saint-Guibert, Wallonia, Belgium calendar_todayFounded 2020 groups8 employees language esobiotec.com

Registered entities

Investor mix

6 investors on record; lead investors include UCB Ventures, Thuja Capital, Sambrinvest, Wallonie Entreprendre.

Investor typeCountShare
Venture capital350%
Private equity233%
Other / undisclosed117%
Coming soon